Alcohol withdrawal other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
| [[File:Siren.gif|30px|link= Alcohol withdrawal resident survival guide]]|| <br> || <br> | | [[File:Siren.gif|30px|link= Alcohol withdrawal resident survival guide]]|| <br> || <br> | ||
| [[Alcohol withdrawal resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | | [[Alcohol withdrawal resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | ||
| Line 8: | Line 7: | ||
'''For patient information click [[Alcohol withdrawal (patient information)|here]].''' | '''For patient information click [[Alcohol withdrawal (patient information)|here]].''' | ||
{{ | {{CMG}} {{AE}} {{SHA}} | ||
==Overview== | |||
There are no other [[diagnostic studies]] associated with [[alcohol]] withdrawal. However, studies with [[neurochemical]] brain [[imaging]] have shown the [[neurochemical]] effects during [[alcohol]] dependence and withdrawal. | |||
==Other Diagnostic Studies== | |||
* There are no other [[diagnostic studies]] associated with [[alcohol]] withdrawal. | |||
* However, studies with [[neurochemical]] brain [[imaging]] [with [[MRS|magnetic resonance spectrometry (MRS)]], [[PET|positron emission tomography (PET)]], and [[SPECT|single photon emission computed tomography (SPECT)]]] have shown the [[neurochemical]] ([[GABA]], [[glutamate]], and [[dopamine]]) effects during [[alcohol]] dependence and withdrawal such as:<ref name="pmid26510169">{{cite journal| author=Hillmer AT, Mason GF, Fucito LM, O'Malley SS, Cosgrove KP| title=How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal. | journal=Alcohol Clin Exp Res | year= 2015 | volume= 39 | issue= 12 | pages= 2268-82 | pmid=26510169 | doi=10.1111/acer.12893 | pmc=4712074 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26510169 }} </ref> | |||
** [[Downregulation]] of [[dopamine]] D2/D3 receptor | |||
** Higher [[glutamate]] levels during acute [[alcohol]] withdrawal followed by fluctuating concentrations | |||
** Potential detrimental effects on the [[GABA]] system by [[smoking]] | |||
==References== | ==References== | ||
Latest revision as of 13:54, 13 November 2020
 |
Resident Survival Guide |
|
Alcohol Withdrawal Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alcohol withdrawal other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Alcohol withdrawal other diagnostic studies |
|
Risk calculators and risk factors for Alcohol withdrawal other diagnostic studies |
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
There are no other diagnostic studies associated with alcohol withdrawal. However, studies with neurochemical brain imaging have shown the neurochemical effects during alcohol dependence and withdrawal.
Other Diagnostic Studies
- There are no other diagnostic studies associated with alcohol withdrawal.
- However, studies with neurochemical brain imaging [with magnetic resonance spectrometry (MRS), positron emission tomography (PET), and single photon emission computed tomography (SPECT)] have shown the neurochemical (GABA, glutamate, and dopamine) effects during alcohol dependence and withdrawal such as:[1]
References
- ↑ Hillmer AT, Mason GF, Fucito LM, O'Malley SS, Cosgrove KP (2015). "How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal". Alcohol Clin Exp Res. 39 (12): 2268–82. doi:10.1111/acer.12893. PMC 4712074. PMID 26510169.